Yanina Grant-Huerta sold $24k of ATRA
Chief Accounting Officer at Atara Biotherapeutics, Inc.. 1,804 shares at an average of $13.19, traded Nov 17, 2025, filed Nov 19, 2025.
Score components
- +15RoleOfficer
- 0Trade size$24k at market
- 0Share of holdings soldSold 5.1% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000905148-25-004140, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 17, 2025 | SOpen-market sale Common Stock | -1,645 | $13.19 | $22k | 33,613 | Nov 19, 2025 |
| Nov 17, 2025 | SOpen-market sale Common Stock | -85 | $13.19 | $1,121 | 33,528 | Nov 19, 2025 |
| Nov 17, 2025 | SOpen-market sale Common Stock | -74 | $13.19 | $976 | 33,454 | Nov 19, 2025 |
Related signals
Other insiders at Atara Biotherapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 50Moderate | ATRAbuy Atara Biotherapeutics, Inc. | Brian N Cherry director | $1000k 104,166 shares | +167% | |
| 33Weak | Atara Biotherapeutics, Inc. | AnhCo Nguyen President and CEO | $15k 2,996 shares | -5% | |
| 23Weak | Atara Biotherapeutics, Inc. | Yanina Grant-Huerta Chief Accounting Officer | $11k 2,104 shares | -6% | |
| 33Weak | ATRAsell Atara Biotherapeutics, Inc. | James Huang director, owner | $489k 80,554 shares | -6% | |
| 39Weak | Atara Biotherapeutics, Inc. | AnhCo Nguyen President and CEO | $38k 2,915 shares | -4% | |
| 23Weak | Atara Biotherapeutics, Inc. | Yanina Grant-Huerta Chief Accounting Officer | $21k 1,809 shares | -5% | |
| 39Weak | Atara Biotherapeutics, Inc. | AnhCo Nguyen President and CEO | $34k 2,958 shares | -4% | |
| 48Moderate | ATRAbuy Atara Biotherapeutics, Inc. | James Huang director, owner | $670k 55,000 shares | +4% | |
| 35Weak | ATRAbuy Atara Biotherapeutics, Inc. | James Huang director, owner | $186k 19,335 shares | +1% | |
| 33Weak | Atara Biotherapeutics, Inc. | AnhCo Nguyen President and CEO | $22k 3,276 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.